Pending — not yet graded
“Bullish on Dr Reddy’s Labs, recommending a buy at ₹1165 with a target of ₹1290 and a stop loss at ₹1100. The stock is attempting to form a base after a corrective phase, finding strong support around its crucial 200-week EMA near ₹1,102.80. This demand zone could provide a base for an upcoming bullish reversal.”
Sumeet Bagadia’s track record: 6 graded calls · 95% CI 19–81%
Dr Reddy's LaboratoriesBullishCalled 12 Sep 2026
This call hasn't reached its evaluation window yet — the HIT/MISS verdict will appear here once it's graded against real price data. Save it above to find it again from your profile.